Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
2023's Best 10 Cell phone Advancements You Can't Miss - 2Ukraine demands army of 800,000 under peace plan
- 3One dead, six wounded in various crime-related shootings in Israel over the weekend
- 4The Excursion to Monetary Proficiency: Individual budget Triumphs
- 5Asia's Noteworthy Destinations: A Voyager's Aide
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
- 21 Things You Ought to Never Tell Your Childless Companion
- Vote In favor of Your #1 sort of film
- 5 Food varieties to Remember for Your Eating regimen for Ideal Wellbeing
- The most effective method to Comprehend the Variables Affecting Medical attendant Pay rates
- Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
- Support Your Body: A Manual for Smart dieting and Sustenance
- 4 Coolers for Present day Kitchens
- Every year, she thanks the trooper for the arrest that led to her sobriety
